Endospheres Therapy: How Compressive Microvibration Actually Works

Lana Sculpt Studio is a non-medical studio. Nothing on this page is medical advice, a diagnosis, or a substitute for care from a clinician.

Lana Sculpt Studio operates this device. Everything below is sourced, and where the sources run out we say where and how far. Every database search described on this page was run in August 2026.

What is Endospheres Therapy?

Endospheres Therapy is a non-invasive body and facial treatment performed with a motorised handpiece containing a rotating cylinder of small spheres. As the cylinder turns against the skin, it applies rhythmic compression and low-frequency vibration to the tissue underneath. The manufacturer calls this combination Compressive Microvibration, a registered trademark of Fenix Group.

The physical design matters more than the branding. A cylinder is mounted inside the handpiece. Set into that cylinder, in a honeycomb pattern, are the spheres — 55 hypoallergenic silicone spheres on the body handpiece, 60 gel micro-spheres on the facial handpiece, according to the manufacturer’s own product pages. The operator moves the handpiece across the skin. The rotation direction and the pressure applied produce the compressive element; varying the rotation speed produces the vibration element. The result is a pulsed, repeating squeeze-and-release rather than a steady push.

That is the whole mechanical story. There is no radiofrequency current, no laser, no ultrasound, no injection and no suction. There is no heating element either — but mechanical work still warms tissue. The one independent vibration study that measured it found skin temperature rose significantly after a single session. The warmth you feel is friction and increased perfusion, not a heating mode.

Who makes the device, and where?

Endospheres is developed and manufactured by Fenix Group, an Italian company based in Città Sant’Angelo in the province of Pescara, with a United States entity, Fenix Group USA Inc., in Miami Beach, Florida. Fenix Group owns the Endospheres and Compressive Microvibration trademarks and states that the devices are manufactured entirely in Italy.

Several generations exist in the current range, including EOS and Evolution, with the FDA device listing filed under the proprietary name AKSENSORALL ENDOSPHERE. The differences between generations are mostly in the control system rather than in the physics — the Evolution body handpiece, for example, is described as carrying three sensors that read tissue in real time and adjust parameters automatically, and offers interchangeable rotors with either gel or silicone spheres.

One specification is harder to pin down than it should be: the vibration frequency. Fenix Group does publish a Technical Dossier (Fascicolo Tecnico) as a free PDF from its own website, and we read it. It carries no frequency figure: the constructional characteristics and technical data are deferred to annexes 4, 5, 6, 7 and 9, which are not included in the public file. Meanwhile, third-party distributor and clinic pages quote four different ranges, none of which names a manufacturer document as its source.

Until those annexes are published, treat any specific Hz number on a salon website as unsourced. There is also a physical reason to doubt the higher numbers. A roller carrying 55 spheres would have to spin at implausible speed to deliver 355 compressions per second at the skin. Figures in the hundreds of hertz are far more likely to describe something inside the drive electronics than the rhythm your tissue actually experiences.

How does compressive microvibration actually work?

Compressive Microvibration is Fenix Group’s trademarked term for applying rhythmic mechanical compression and low-frequency vibration to tissue using a rotating cylinder of spheres held in a handpiece. Three mechanisms are claimed for it: stimulation of lymphatic flow, increased microcirculation, and remodelling of connective tissue. The first two rest on established physiology the device plausibly engages. The third is the one most often oversold.

Does it move lymph?

Endospheres Therapy can plausibly assist lymph movement, but only through one narrow route. About two-thirds of lymph flow at rest is generated by lymphatic vessels contracting on their own; the remaining third comes from external compression of the surrounding muscle and tissue as the body moves. A rolling, cyclically compressing handpiece acts on that external third and on nothing else.

The lymphatic system transports 8 to 12 litres of fluid a day. The intrinsic two-thirds comes from collecting vessels invested with pericytes containing alpha-smooth muscle actin, contracting behind one-way valves. Rhythmic external compression raises interstitial pressure, and lymphatic capillaries have overlapping “button-like” endothelial junctions that open when interstitial pressure exceeds the pressure inside the vessel. That is established physiology, not a device claim. A rolling handpiece is a reasonable way to apply that stimulus consistently over a large surface area.

What does not follow is the word “detox”. Lymph is not a toxin reservoir and moving it faster does not remove poisons. It carries interstitial fluid, protein and immune cells back to the bloodstream. The honest framing is fluid distribution and how the skin looks and feels, not purification. We go into this further in what lymphatic drainage actually does and does not do.

There is also a hard limit worth naming. Lymphoedema is a medical diagnosis with a medical treatment pathway, and a 2021 systematic review of 17 studies in the Journal of Cancer Survivorship found the evidence for manual lymphatic drainage itself conflicting: some benefit in prevention and mild cases, no clear additional benefit when added to complete decongestive therapy in moderate-to-severe cases. If the evidence for the hands-on original is that mixed, no device version of it should be presented as more certain.

Does it change microcirculation?

Endospheres Therapy probably increases local skin blood flow for a short period after a session. Local mechanical vibration has been shown in independent human studies to raise cutaneous perfusion, with nitric oxide release proposed as the mediator. The effect is measured in minutes to hours rather than weeks, and there is no evidence it accumulates across a course of treatments.

The device-specific version of this claim has been tested once, in a small study. Kardashova and colleagues used laser Doppler flowmetry on 27 women aged 40 to 69 after a course of compression microvibration and reported statistically significant increases in basal blood flow parameters. That is a real measurement with a real instrument. It is also 27 people, with no control group, published in the Pacific Medical Journal in 2024, by a group that has published at least five papers on this one method — largely on the same cohort, and one of them co-authored with the method’s own scientific director.

Separately, a 2022 study in the International Journal of Environmental Research and Public Health looked at a different vibration device entirely — a Vitberg MMT oscillatory-cycloidal unit running at 18–39 Hz — in 57 women with grade 1–2 cellulite over 15 sessions in three weeks. Participants were allocated to four groups differing in session length, but there was no untreated and no sham group, so the comparison is between doses rather than against nothing. Skin temperature rose measurably after treatment, and 54.55% of grade 1 cases were reclassified as grade 0, with 51.43% of grade 2 cases moving to grade 1. Those grades come from the Nürnberger-Müller scale, a four-point visual classification (0 to 3) applied at rest and on pinching by an assessor who knows the participant has been treated. The study did not test Endospheres, so it cannot be transferred directly. It does suggest that the general category — repeated local mechanical vibration — is not physiologically inert.

Does it change connective tissue and the appearance of skin?

There is no controlled evidence that Endospheres Therapy remodels connective tissue. The claim is that cyclic mechanical stress alters fibroblast behaviour and reshapes the fibrous septa that cause cellulite dimpling. Mechanotransduction is real biology, but no randomised or sham-controlled trial has tested whether a rolling handpiece delivers enough force to change septa — and the manufacturer’s own regulatory file describes the device as acting on skin only, not in depth.

That last point settles the question more bluntly than the literature does. Fenix Group’s public Technical Dossier declares the device to be one for “massaggi meccanici solo a livello cutaneo e non in profondità” — mechanical massage at skin level only and not in depth. A manufacturer that classifies its own product as acting only superficially in order to stay outside medical device regulation is not in a position to claim, in marketing, that the same product remodels fibrous septa in the subcutis. Those two statements cannot both be true, and the one filed with a regulator is the one to believe.

The dermatological literature is not encouraging on this point in general. Cellulite is a multifactorial condition present in 80–90% of post-pubertal women, driven substantially by the architecture of fibrous septa tethering skin to deeper tissue. A 2024 review in Aesthetic Plastic Surgery concluded that among non-invasive options radiofrequency demonstrates the strongest efficacy in the current peer-reviewed literature, and that severe cellulite responds best to approaches that physically target the septa, such as subcision. The American Academy of Dermatology is blunter still about the mechanical category, noting for endermologie-type treatment that study results vary and that “the cellulite tends to return within 1 month of stopping treatment.” There is more on this in what the dermatology evidence says about cellulite treatments.

Set the three claims side by side and the asymmetry is easy to see.

What does a session physically feel like?

An Endospheres session feels firm, warm, buzzing and rhythmic. The handpiece is moved in slow passes along the limb or torso, usually working toward the nearest lymph node groups. Most people describe a deep vibrating roll: noticeably more intense than a light massage, and considerably less sharp than a vacuum-roller device that pulls skin up into a chamber.

It should not hurt. If it does, say so and have the session stopped, not merely turned down — then have the practitioner check the area before restarting. Pain during a mechanical massage can mean the settings are wrong, and it can also mean something in the tissue should not be worked at all.

That instruction only works if you can feel pain in the first place. Do not have this treatment if you have reduced or absent sensation in the area to be treated — diabetic peripheral neuropathy, nerve injury, spinal cord injury, or any condition that dulls touch or pain. Pain is the only warning this treatment gives you, and if it cannot reach you the safety margin is gone.

Skin is usually left slightly pink for 20 to 60 minutes afterwards, which is consistent with a local increase in cutaneous blood flow. Some people feel an increased need to urinate in the hours afterwards, which is what you would expect from redistributing interstitial fluid, not from any elimination of anything else. Mild tenderness the next day is not unusual on areas that were worked firmly. What a first session feels like is covered in more detail separately.

Contact a doctor promptly, and do not book another session, if after a treatment you develop pain, swelling, warmth or redness in one calf; bruising that is extensive or that you cannot account for; a spreading rash; a fever; or breathlessness. Calf pain and one-sided swelling in particular need same-day assessment.

How long is a session, and how many are typical?

An Endospheres session typically runs 30 to 45 minutes for a single body area, 45 to 60 minutes for full-body work, and 20 to 30 minutes for the face, with courses of 8 to 12 sessions at one or two per week. Those are studio conventions, not manufacturer protocols: Fenix Group publishes no session length or course count anywhere.

The one published protocol is worth knowing because it is the basis for most of the numbers circulating online: 12 sessions of 60 minutes, twice weekly, over roughly six weeks, using an Endospheres Therapy Body unit. That is the protocol used in the 27-participant Russian studies. We set out our own scheduling logic in how many sessions a course typically runs.

How is it different from a hand massage?

Endospheres Therapy differs from hand massage in consistency and parameter control, not in effectiveness. A therapist adapts continuously to what they feel and works at very light pressure; the device applies the same pressure and rhythm across a large area for 45 minutes without fatigue, with a superimposed vibration no hand can produce. They are different stimuli, not a better and a worse one.

This table compares mechanisms, not indications. Endospheres Therapy is not offered for, and must not be substituted for, any medically supervised treatment listed in the manual lymphatic drainage column. A fuller side-by-side sits in Endospheres compared with manual lymphatic drainage.

What does the published research actually say?

The published research on Endospheres Therapy runs to roughly ten papers, none indexed in PubMed or Europe PMC, none randomised or sham-controlled, and every one of them authored by or co-authored with the method’s own scientific directors. They sit in the Journal of Applied Cosmetology and in Russian rehabilitation journals. Participants total around 180, with one 27-woman cohort reported at least three separate times.

Five things follow from that table.

First, none of this work is indexed in PubMed or Europe PMC. A phrase search of PubMed for “compressive microvibration” returns the message that the phrase is not in the index; Europe PMC returns an empty result set for both “compressive microvibration” and “Endospheres Therapy”. The Journal of Applied Cosmetology has an NLM Catalog record (NLM ID 8410045) but its articles do not appear in PubMed search results.

Second, there is no independent strand. The Italian body of work is authored by Professor Pier Antonio Bacci and Professor Raoul Saggini, described by the journal itself as having directed the scientific rationale for the method. The Moscow group that produced the Russian papers co-published with Bacci in the Journal of Applied Cosmetology in 2023. No conflict-of-interest statement is retrievable on any of these records. That does not make the work wrong. It does mean none of it is independent verification, and the whole corpus should be read as manufacturer-linked.

Third, the size of the evidence base is smaller than the headcount suggests. Across all located Endospheres-specific clinical publications the participant total is roughly 180, not the low dozens. That number flatters the evidence base rather than describing it: the same 27-woman Russian cohort is reported at least three separate times under different endpoints, and the 100-participant study is confounded by a concurrent ketogenic diet in both arms, so the number of participants who tested Endospheres in isolation against any comparator is zero. The largest study of the device used alone enrolled 30 patients in two arms of 15.

Fourth, the numbers most often quoted from the 2022 Russian study need care. The 16.4% fat mass index fall applies to one age group of nine women. The waist reduction of 2.2–3.0 cm and hip reduction of 4.1–6.3 cm are the spread across three separate groups of nine. The same abstract also reports a weight loss of 3.4–7.4 kg over six weeks, with no control group, no blinding and no reported control of diet or physical activity. A rolling massage handpiece cannot plausibly cause a seven-kilogram weight loss; a number that size points to uncontrolled confounding, not to a device effect, and it should reduce your confidence in the study’s other figures rather than raise it. We do not present Endospheres as a fat-loss or weight-loss treatment, and neither should anyone else.

In cellulite research the absence of a control group matters more than usual, because the standard endpoints — visual grading, circumference, and self-reported satisfaction — are all unblinded and all move in the direction the assessor expects. The 2015 systematic review found this to be the field’s characteristic flaw, not an occasional one.

Fifth, the most widely circulated performance figures have no retrievable source, and they start with the manufacturer rather than with salons. Fenix Group’s own website displays “97.8% satisfied customers”, footnoted only to “Endospheres® Scientific Studies” with no citation, alongside the claim that “The results are clinically proved by Universities and Research Intitutes” [sic] — also uncited. Clinic pages expand this into “656 patients across 24 medical centres, 39% average cellulite decrease, 97.8% satisfaction” and attribute it to Bacci. Searches of PubMed, Europe PMC and Crossref surfaced no primary publication reporting any of those three numbers. The nearest real figure in the literature is a 40.14% fall in a composite thermographic-and-clinical score in 20 patients over twelve sessions (Bacci et al., Journal of Applied Cosmetology 2021;39(2):60–80). Any US studio repeating the 97.8% figure without a retrievable study is carrying the substantiation risk itself. Under FTC advertising substantiation principles, the business making a performance claim carries the burden of proof for it, and “the manufacturer said so” is not substantiation.

What about durability — does anything last?

Two uncontrolled studies from the same research group report that ultrasonographic and perfusion changes were still measurable 60 days after the course ended. No study followed anyone beyond 60 days, and neither study had a control group, so what those results actually show is that a measurement drifted back less than expected in people who knew they had been treated. Durability beyond two months is unknown, and even the two-month figure has no comparator.

What is the regulatory status in the United States?

Fenix Group Srl appears in the FDA establishment registration and listing database under registration number 3011197718, with proprietary name “AKSENSORALL ENDOSPHERE”, device name “Massager, Therapeutic, Electric”, product code ISA, and a US agent in Georgia. Product code ISA corresponds to 21 CFR 890.5660, which defines a therapeutic massager as “an electrically powered device intended for medical purposes, such as to relieve minor muscle aches and pains”, classifies it as Class I, and states that it “is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 890.9.”

Class I, 510(k)-exempt means the manufacturer registers the establishment and lists the device but does not submit a premarket notification for FDA to review. A query of the openFDA 510(k) database for applicants named Fenix returns no clearance record; openFDA returns HTTP 404 rather than an empty list when a device query has no matches, which is what the applicant search for Fenix returns. By contrast, LPG’s vacuum-roller devices do hold 510(k) clearances under the same ISA product code — K990445 (18 January 2000) and K053225 (6 November 2006) — so a clearance in this category is possible and observable when it exists.

This matters because at least one manufacturer page describes Compressive Microvibration as “our FDA-approved system”. Under FDA terminology, “approved” applies to devices that have been through premarket approval, a pathway reserved for high-risk Class III devices. A Class I exempt massager has neither approval nor clearance. There is no clearance number to produce, because none exists.

A US studio that repeats “FDA-approved” about this device in its own advertising is not merely using a loose word. Under 21 U.S.C. 352 that representation can render a device misbranded, and it is independently actionable by the FTC as a deceptive claim. Do not use the phrase, and ask any studio that does to show you the clearance number.

And in the European Union?

In the European Union the device is not a medical device. Fenix Group’s own public Technical Dossier declares Endospheres Therapy as an “apparecchio per massaggi meccanici solo a livello cutaneo e non in profondità” — a mechanical massage appliance acting at skin level only and not in depth — under sheet 6a of Italian Decree 206 of 15 October 2015, which governs electromechanical equipment used by beauticians. CE marking is claimed under the Low Voltage Directive 2014/35/EU and the EMC Directive 2014/30/EU through internal production control, meaning the manufacturer self-declares conformity with no notified body assessing it. The harmonised standards listed are the EN 60335 household-appliance safety series, including EN 60335-2-32 for massage appliances; IEC 60601, the standard for medical electrical equipment, is not among them. No EU medical device conformity is claimed anywhere in the file. So on both sides of the Atlantic this is a massager: Class I and exempt in the United States, self-certified beautician equipment in Italy.

Where the evidence is thin, and what this does not do

Endospheres does not remove fat, cause weight loss, permanently eliminate cellulite, detoxify anything, treat a disease, or substitute for medical care. Lana Sculpt Studio is not a medical provider, and nothing here is a diagnosis.

The evidence gaps, stated plainly:

• There is no randomised, sham-controlled trial of Endospheres. Every clinical study located was uncontrolled, or comparative without blinding, or confounded by a concurrent diet in both arms.
• Roughly 180 participants appear across the whole corpus, but one 27-woman cohort is reported at least three times, and no participant anywhere has tested the device in isolation against a comparator.
• There is no independent literature. The Italian and Russian bodies of work share an author, and that author is the method’s named scientific director.
• Durability is documented only to 60 days, in two uncontrolled studies from that same group. For the closest comparable technology, the AAD notes the effect fades within about a month of stopping.
• The device’s frequency specification is not published. The manufacturer’s public Technical Dossier defers the technical data to annexes 4, 5, 6, 7 and 9, which are not in the public file, and the third-party figures in circulation contradict one another.
• Cellulite research as a field is weak. The 2015 American Journal of Clinical Dermatology review analysed 67 studies, found only 19 were placebo-controlled with randomisation, saw “some evidence for potential benefit… only for acoustic wave therapy (AWT) and the 1440 nm Nd:YAG minimally invasive laser”, and concluded that “no clear evidence of good efficacy could be identified in any of the evaluated cellulite treatments.” Mechanical rolling and massage devices were not among the two partial exceptions.

What can be said with reasonable confidence is narrower and still worth something: the treatment applies a real, controllable mechanical stimulus to tissue; that class of stimulus measurably increases local cutaneous blood flow in independent studies; external compression is a genuine contributor to lymph movement; and most people find the session comfortable and say they feel less puffy and less sore afterwards. That last point is practitioner observation and client self-report, not clinical evidence, and we label it as such.

Who is it suited to, and who should avoid it?

Endospheres Therapy suits people who want a comfortable, non-invasive session aimed at the appearance of skin and the sensation of puffiness, and who accept that no controlled trial has shown it produces a lasting change. It does not suit anyone hoping to alter body composition. Several medical conditions rule it out entirely, and the list below is stricter than the manufacturer’s, which claims there are none.

More specifically, it suits people who want a session focused on the appearance of skin and skin texture, and on the subjective sensation of leg heaviness that some clients describe after long days on their feet. This is not a treatment for venous or lymphatic disease. Leg heaviness or swelling that persists, worsens, or affects one leg more than the other should be assessed by a doctor before you book anything. Some clients also report feeling less sore the day after hard training; that is self-report from our own studio, not a demonstrated therapeutic effect, and no study has tested it. It suits people who prefer consistent mechanical pressure to hands, and who accept that no controlled trial has ever shown this treatment produces a lasting change in appearance, so any result you get may need repeating indefinitely or may not appear at all.

Fenix Group’s own website states that “The treatment can be performed without limits, and there are no contraindications.” That statement is wrong and you should not rely on it. Every intervention that increases circulation and venous return has contraindications. The list below is the one we operate to, and we would rather turn a booking away than treat someone on it.

There is no usable manufacturer contraindication list to reconcile this against. Fenix Group’s public Technical Dossier contains no contraindications section, and its website states that there are none. This list is therefore built from the standard absolute contraindications for manual lymphatic drainage and massage — acute untreated deep vein thrombosis, acute infection or cellulitis, untreated congestive heart failure, renal failure and fever — plus ordinary clinical caution. Where it is stricter than the manufacturer, that is deliberate. If you are unsure whether something on that list applies to you, ask your physician before booking, not after. We expand on the reasoning in who should avoid Endospheres Therapy.

Questions people ask

Is Endospheres Therapy FDA approved? No. Fenix Group Srl is listed in the FDA establishment registration database under product code ISA, “Massager, Therapeutic, Electric”, a Class I device under 21 CFR 890.5660 that is exempt from premarket notification. An openFDA 510(k) query on applicants named Fenix returns HTTP 404, openFDA’s response to a zero-result search, so there is no clearance either. “Approved” is FDA terminology for premarket-approved Class III devices and does not apply. A business that advertises this device as FDA-approved risks a misbranding exposure under 21 U.S.C. 352 and an FTC deception claim.

Does Endospheres reduce fat or cause weight loss? No, and it should not be offered on that basis. One uncontrolled study of 27 women reported a 16.4% fall in bioimpedance-derived fat mass index in one age group of nine, and the same abstract reports a weight loss of 3.4–7.4 kg over six weeks with no control group, no blinding and no reported control of diet or activity. A rolling massage handpiece cannot plausibly cause a seven-kilogram weight loss, which is a reason to distrust the study rather than the device. Circumference changes during drainage-style treatment are compatible with fluid shift.

How many sessions before anything is visible? Most Endospheres studio protocols run 8 to 12 sessions at one or two per week, and the one published clinical protocol used 12 sixty-minute sessions twice weekly over six weeks. Skin is commonly pink straight afterwards, which is a short-lived circulatory effect. Many clients also say they feel less puffy immediately after a session; that is self-report following a treatment they chose and paid for, and no controlled study has tested it. Two uncontrolled studies report changes still measurable at 60 days; nothing has been followed beyond that.

Does it hurt? Endospheres Therapy should not hurt. The sensation is a firm, vibrating roll: more intense than a light massage, less sharp than a vacuum-roller device that draws skin into a chamber. Pressure and rotation speed are adjustable, so pain means the settings are wrong. Say so and have the session stopped rather than merely turned down, and have the practitioner check the area before restarting. Do not book at all if you have reduced sensation in the area, because pain is the only warning the treatment gives you.

Is it better than manual lymphatic drainage? Endospheres Therapy is different from manual lymphatic drainage, not better than it. Manual drainage uses very light pressure and continuous therapist adaptation; the device applies a firmer, faster, more consistent stimulus over larger areas. Neither has strong evidence behind it: a 17-study systematic review of manual drainage found conflicting results, with no clear added benefit within complete decongestive therapy for moderate-to-severe lymphoedema, and no controlled trial of Endospheres exists at all.

Can it treat lymphoedema? Endospheres Therapy is not a treatment for lymphoedema. One manufacturer-linked study of 100 women did apply it to lymphoedema alongside a ketogenic diet, but with no untreated and no sham arm it cannot show what the device contributed. Lymphoedema is a medical diagnosis requiring medical management, and a studio session is not a substitute for that pathway. Lana Sculpt Studio is not a medical provider. If you have diagnosed lymphoedema, or a limb where lymph nodes were removed or irradiated, speak to the clinician managing it before booking anything.

Are there any independent studies? No. Nothing specific to Endospheres is indexed in PubMed or Europe PMC, and there is no independent strand in the literature at all: the Italian papers are authored by the method’s own scientific directors, and the Moscow group behind the Russian papers co-published with one of them in 2023. Independent evidence exists only for the broader category of local mechanical vibration and cutaneous blood flow, in studies that did not use this device.

Does the manufacturer really say there are no contraindications? Yes, and that statement should not be relied on. Fenix Group’s product page states that “The treatment can be performed without limits, and there are no contraindications.” Its public Technical Dossier contains no contraindications section either. Every intervention that increases circulation and venous return has contraindications, and the list this studio operates to is deliberately stricter than the manufacturer’s. It is built from the standard absolute contraindications for manual lymphatic drainage and massage: acute untreated deep vein thrombosis, acute infection or cellulitis, untreated congestive heart failure, renal failure and fever, plus ordinary clinical caution.